NORDITROPIN Side Effects

7010118-5 | Eye Swelling, Headache, Lip Swelling, Nausea, Pyrexia
on Sep 16, 2010 Female patient from ITALY , weighting 50.71 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: eye swelling, headache (What is headache?), lip swelling, nausea (What is nausea?), pyrexia. Norditropin dosage: 0.83 Mg, Qd. Patient was hospitalized.

7007184-X | Asthma
Patient was taking Norditropin (View Usage). Patient had the following side effects: asthma (What is asthma?) on Sep 08, 2010 from DENMARK Additional patient health information: Male patient , child 10 years of age, weighting 46.30 lb, was diagnosed with growth hormone deficiency and. Norditropin dosage: 1 Mg, Qd. During the same period patient was treated with SALBUTAMOL (Respiratory) (View Salbutamol Review and Salbutamol Label ), MOMETASONE FUROATE (50 Mg Per Dose) (View Mometasone Furoate Review and Mometasone Furoate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BUDESONIDE (Respiratory) (View Budesonide Review and Budesonide Label ), FORMOTEROL FUMARATE (12 Mg) (View Formoterol Fumarate Review and Formoterol Fumarate Label ). Patient was hospitalized.

6999073-1 | Asthma
Adverse event was reported on Sep 08, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: 1 Mg, Qd) was diagnosed with growth hormone deficiency and. Location: DENMARK , child 10 years of age, weighting 46.30 lb, After Norditropin was administered, patient had the following side effects: asthma (What is asthma?). During the same period patient was treated with SALBUTAMOL (Respiratory) (View Salbutamol Review and Salbutamol Label ), MOMETASONE FUROATE (50 Mg Per Dose) (View Mometasone Furoate Review and Mometasone Furoate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BUDESONIDE (Respiratory) (View Budesonide Review and Budesonide Label ), FORMOTEROL FUMARATE (12 Mg) (View Formoterol Fumarate Review and Formoterol Fumarate Label ). Patient was hospitalized.

6957559-X | Brain Neoplasm
on Aug 20, 2010 Male patient from DENMARK , 15 years of age, weighting 109.3 lb, was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: brain neoplasm. Norditropin dosage: Unk. Patient was hospitalized.


6940149-2 | Hypoglycaemic Unconsciousness
on Aug 18, 2010 Female patient from UNITED STATES , weighting 15.23 lb, was diagnosed with hypopituitarism and was treated with Norditropin (View Usage). Patient had the following side effects: hypoglycaemic unconsciousness. Norditropin dosage: 0.3 Mg, Qd. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), REGLAN (View Reglan Review and Reglan Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6905619-1 | Bone Cyst, Bone Disorder
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: bone cyst, bone disorder on Jul 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 127.2 lb, was diagnosed with growth hormone deficiency, asthma (What is asthma?), rhinitis allergic and. Norditropin dosage: 2.6 Mg, Qd. During the same period patient was treated with ADVAIR DISKUS 100/50 (Unk) (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), CLARINEX /01202601/ (Unk) (View Clarinex /01202601/ Review and Clarinex /01202601/ Label ), SINGULAIR (Unk) (View Singulair Review and Singulair Label ), NEXIUM (Unk) (View Nexium Review and Nexium Label ), NASACORT (Unk) (View Nasacort Review and Nasacort Label ), MINOCIN (Unk) (View Minocin Review and Minocin Label ).

6879569-3 | Brain Neoplasm
Adverse event was reported on Jul 22, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: ) . Location: DENMARK , 15 years of age, Patient experienced the following unwanted or unexpected effects: brain neoplasm.

6844670-7 | Oral Neoplasm
on Jul 07, 2010 Male patient from GERMANY , weighting 57.32 lb, was diagnosed with small for dates baby and was treated with Norditropin (View Usage). Patient had the following side effects: oral neoplasm. Norditropin dosage: 0.8 Mg, Qd.

6819321-8 | Decreased Appetite, Headache, Intracranial Pressure Increased, Malaise, Papilloedema, Strabismus, Vith Nerve Paralysis, Vomiting
on Jun 30, 2010 Male patient from JAPAN , child 4 years of age, weighting 24.25 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: decreased appetite, headache (What is headache?), intracranial pressure increased, malaise, papilloedema, strabismus, vith nerve paralysis, vomiting. Norditropin dosage: 1.9 Mg/week. Patient was hospitalized.

6809759-7 | Pituitary Tumour Benign
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: pituitary tumour benign on Jun 23, 2010 from GERMANY Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with growth hormone deficiency and. Norditropin dosage: .2 Mg, Qd. During the same period patient was treated with FLUVASTATIN (Unk) (View Fluvastatin Review and Fluvastatin Label ), RAMIPRIL (Unk) (View Ramipril Review and Ramipril Label ), TAMSULOSIN HCL (Unk) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ).

6790127-1 | Alopecia
Adverse event was reported on Jun 14, 2010 by a Female patient taking Norditropin (View Usage) (Dosage: 0.72 Mg Daily, 6 Days/week) was diagnosed with growth hormone deficiency and. Location: FRANCE , child 10 years of age, weighting 46.30 lb, Patient had the following side effects: alopecia.

6770037-6 | Bone Sarcoma
on Jun 07, 2010 Male patient from FRANCE , child 12 years of age, weighting 77.16 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: bone sarcoma. Norditropin dosage: 1.2 Mg, 6 Days Per Week. Patient was hospitalized.

6757696-9 | Epiphyseal Fracture, Epiphysiolysis, Fall
on May 26, 2010 Female patient from UNITED STATES , 13 years of age, was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: epiphyseal fracture, epiphysiolysis, fall (What is fall?). Norditropin dosage: . During the same period patient was treated with LUPRON (View Lupron Review and Lupron Label ).

6753170-4 | Eye Swelling, Headache, Lip Swelling, Nausea, Pyrexia
Patient was taking Norditropin (View Usage). Patient had the following side effects: eye swelling, headache (What is headache?), lip swelling, nausea (What is nausea?), pyrexia on May 27, 2010 from ITALY Additional patient health information: Female patient , weighting 50.71 lb, was diagnosed with growth hormone deficiency and. Norditropin dosage: 0.83 Mg, Qd. Patient was hospitalized.

6745836-7 | Asthma
Adverse event was reported on May 21, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: 1 Mg, Qd) . Location: DENMARK , child 10 years of age, weighting 46.30 lb, After Norditropin was administered, patient had the following side effects: asthma (What is asthma?). During the same period patient was treated with SALBUTAMOL (Respiratory) (View Salbutamol Review and Salbutamol Label ), MOMETASONE FUROATE (50 Mg Per Dose) (View Mometasone Furoate Review and Mometasone Furoate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BUDESONIDE (Respiratory) (View Budesonide Review and Budesonide Label ), FORMOTEROL (12 Mg) (View Formoterol Review and Formoterol Label ). Patient was hospitalized.

6723607-5 | Papilloedema
on May 03, 2010 Female patient from UNITED STATES , weighting 71.39 lb, was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: papilloedema. Norditropin dosage: . During the same period patient was treated with ESTRADIOL (0.00625 Mg Weekly) (View Estradiol Review and Estradiol Label ).

6686388-X | Eye Swelling, Headache, Lip Swelling, Nausea, Pyrexia
on Apr 09, 2010 Female patient from ITALY , weighting 50.71 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient had the following side effects: eye swelling, headache (What is headache?), lip swelling, nausea (What is nausea?), pyrexia. Norditropin dosage: 0.83 Mg, Qd. Patient was hospitalized.

6682508-1 | Back Pain, Epstein-barr Virus Associated Lymphoproliferative Disorder, Haemoglobin Decreased, Liver Disorder, Renal Impairment, Sepsis, Upper Respiratory Tract Infection
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: back pain (What is back pain?), epstein-barr virus associated lymphoproliferative disorder, haemoglobin decreased, liver disorder, renal impairment, sepsis (What is sepsis?), upper respiratory tract infection on Apr 07, 2010 from AUSTRALIA Additional patient health information: Male patient , 13 years of age, weighting 82.67 lb, was diagnosed with body height below normal and. Norditropin dosage: 1.5 Mg, Qd. During the same period patient was treated with AZATHIOPRINE (50 Mg, Qd) (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (15 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), TACROLIMUS (12 Mg, Qd) (View Tacrolimus Review and Tacrolimus Label ), ISOTRETINOIN (10 Mg, Qd) (View Isotretinoin Review and Isotretinoin Label ), ENAPRIL /00574901/ (View Enapril /00574901/ Review and Enapril /00574901/ Label ), VALGANCICLOVIR HCL (450 Mg, Bid) (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ). Patient was hospitalized.

6680715-5 | Chest Pain
Adverse event was reported on Apr 13, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 156.0 lb, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?). During the same period patient was treated with VERAPAMIL EXTENDED RELEASE (View Verapamil Extended-release Review and Verapamil Extended-release Label ), VYTORIN (View Vytorin Review and Vytorin Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), MILK (View Milk Review and Milk Label ), CIALIS (View Cialis Review and Cialis Label ), OS CAL (View Os-cal Review and Os-cal Label ). Patient was hospitalized.

6676541-3 | Pituitary Tumour Benign
on Apr 01, 2010 Male patient from GERMANY , weighting 231.5 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). Patient had the following side effects: pituitary tumour benign. Norditropin dosage: 8 Mbq, Qd. During the same period patient was treated with HYDROCORTISON /00028601/ (15 Mg, Qd) (View Hydrocortison /00028601/ Review and Hydrocortison /00028601/ Label ).

6672461-9 | Hepatoblastoma
on Mar 29, 2010 Male patient from UNITED KINGDOM , child 3 years of age, weighting 24.25 lb, was diagnosed with body height below normal, anaemia, renal failure and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: hepatoblastoma. Norditropin dosage: 0.6 Mg, Qd. During the same period patient was treated with NEORECORMON (Unk) (View Neorecormon Review and Neorecormon Label ), ALFACALCIDOL (200 Ng, Qd) (View Alfacalcidol Review and Alfacalcidol Label ), CALAMINE (1 Df, Tid) (View Calamine Review and Calamine Label ), CALCIUM CARBONATE (300 Mg, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ), CHLORPHENIRAMINE MALEATE (1 Mg, Qid) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CINACALCET HYDROCHLORIDE (3.6 Mg, Qd) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), CLOTRIMAZOLE (1 Df, Tid) (View Clotrimazole Review and Clotrimazole Label ), COLECALCIFEROL (Unk) (View Colecalciferol Review and Colecalciferol Label ). Patient was hospitalized.

6670698-6 | Hypoglycaemic Unconsciousness
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic unconsciousness on Mar 30, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 15.23 lb, was diagnosed with hypopituitarism and. Norditropin dosage: 0.3 Mg, Qd. Patient was hospitalized.

6660803-X | Eye Swelling, Lip Swelling
Adverse event was reported on Mar 22, 2010 by a Female patient taking Norditropin (View Usage) (Dosage: 0.83 Mg, Qd) was diagnosed with growth hormone deficiency and. Location: ITALY , child 8 years of age, Patient had the following side effects: eye swelling, lip swelling. Patient was hospitalized.

6660464-X | Colorectal Cancer
on Mar 25, 2010 Male patient from SWEDEN , 18 years of age, weighting 123.5 lb, was diagnosed with growth retardation and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: colorectal cancer (What is colorectal cancer?). Norditropin dosage: 2 Mg, Qd. During the same period patient was treated with VITAMINERAL (1 Tab, Qd) (View Vitamineral Review and Vitamineral Label ), PIKASOL (2000 Mg, Qd) (View Pikasol Review and Pikasol Label ), NIFEREX /00023501/ (100 Mg, Unk) (View Niferex /00023501/ Review and Niferex /00023501/ Label ).

6651122-6 | Oral Neoplasm
on Mar 19, 2010 Male patient from GERMANY , weighting 57.32 lb, was diagnosed with small for dates baby and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: oral neoplasm. Norditropin dosage: 0.8 Mg, Qd.

6650267-4 | Condition Aggravated, Epilepsy
Patient was taking Norditropin (View Usage). Patient had the following side effects: condition aggravated, epilepsy (What is epilepsy?) on Mar 16, 2010 from NETHERLANDS Additional patient health information: Male patient , weighting 105.8 lb, was diagnosed with noonan syndrome and. Norditropin dosage: 2 Mg, Qd.

6647984-9 | Rhabdomyosarcoma
Adverse event was reported on Mar 18, 2010 by a Female patient taking Norditropin (View Usage) (Dosage: 2.2 Mg, Unk) . Location: UNITED KINGDOM , 16 years of age, weighting 138.0 lb, After Norditropin was administered, patient had the following side effects: rhabdomyosarcoma. Patient was hospitalized.

6645756-2 | Hepatoblastoma
on Mar 18, 2010 Male patient from UNITED KINGDOM , child 3 years of age, weighting 24.25 lb, was diagnosed with body height below normal, anaemia, renal failure and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatoblastoma. Norditropin dosage: 0.6 Mg, Qd. During the same period patient was treated with NEORECORMON (Unk) (View Neorecormon Review and Neorecormon Label ), ALFACALCIDOL (200 Ng, Qd) (View Alfacalcidol Review and Alfacalcidol Label ), CALAMINE (1 Df, Tid) (View Calamine Review and Calamine Label ), CALCIUM CARBONATE (300 Mg, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ), CHLORPHENIRAMINE MALEATE (1 Mg, Qid) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CINACALCET HYDROCHLORIDE (3.6 Mg, Qd) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), CLOTRIMAZOLE (1 Df, Tid) (View Clotrimazole Review and Clotrimazole Label ), COLECALCIFEROL (Unk) (View Colecalciferol Review and Colecalciferol Label ). Patient was hospitalized.

6645755-0 | Rhabdomyosarcoma
on Mar 18, 2010 Female patient from UNITED KINGDOM , 16 years of age, weighting 138.0 lb, was treated with Norditropin (View Usage). Patient had the following side effects: rhabdomyosarcoma. Norditropin dosage: 2.2 Mg, Unk. Patient was hospitalized.

6642238-9 | Lymphocytic Leukaemia
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: lymphocytic leukaemia on Mar 10, 2010 from GERMANY Additional patient health information: Male patient , weighting 33.73 lb, was diagnosed with growth hormone deficiency and. Norditropin dosage: .4 Mg, Qd. During the same period patient was treated with HYDROCORTISON /00028601/ (Unk) (View Hydrocortison /00028601/ Review and Hydrocortison /00028601/ Label ), MINIRIN (Unk) (View Minirin Review and Minirin Label ). Patient was hospitalized.

6631737-1 | Skin Striae
Adverse event was reported on Mar 04, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: Unk) was diagnosed with small for dates baby and. Location: GERMANY , weighting 102.3 lb, Patient experienced the following unwanted or unexpected effects: skin striae.

6624741-0 | Tenosynovitis Stenosans
on Mar 01, 2010 Male patient from GREECE , 33 years of age, was diagnosed with off label use and was treated with Norditropin (View Usage). Patient had the following side effects: tenosynovitis stenosans. Norditropin dosage: 4.75 Iu, Qd.

6624740-9 | Tenosynovitis Stenosans
on Mar 01, 2010 Male patient from GREECE , 33 years of age, was diagnosed with off label use and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: tenosynovitis stenosans. Norditropin dosage: 4.75 Iu, Qd.

6623918-8 | Tenosynovitis Stenosans
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: tenosynovitis stenosans on Mar 01, 2010 from GREECE Additional patient health information: Male patient , 33 years of age, was diagnosed with off label use and. Norditropin dosage: 4.75 Iu, Qd.

6623917-6 | Tenosynovitis Stenosans
Adverse event was reported on Mar 01, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: 4.40 Iu, Qd) was diagnosed with off label use and. Location: GREECE , 33 years of age, Patient had the following side effects: tenosynovitis stenosans.

6623915-2 | Tenosynovitis Stenosans
on Mar 01, 2010 Male patient from GREECE , 33 years of age, was diagnosed with off label use and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: tenosynovitis stenosans. Norditropin dosage: 4.4 Iu, Qd.

6623914-0 | Tenosynovitis Stenosans
on Mar 01, 2010 Male patient from GREECE , 33 years of age, was diagnosed with off label use and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: tenosynovitis stenosans. Norditropin dosage: 4.40 Iu, Qd.

6623913-9 | Tenosynovitis Stenosans
Patient was taking Norditropin (View Usage). Patient had the following side effects: tenosynovitis stenosans on Mar 01, 2010 from GREECE Additional patient health information: Male patient , 33 years of age, was diagnosed with off label use and. Norditropin dosage: 4.40 Iu, Qd.

6623912-7 | Tenosynovitis Stenosans
Adverse event was reported on Mar 01, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: 4.75 Iu, Qd) was diagnosed with off label use and. Location: GREECE , 33 years of age, After Norditropin was administered, patient had the following side effects: tenosynovitis stenosans.

6623911-5 | Tenosynovitis Stenosans
on Mar 01, 2010 Male patient from GREECE , 33 years of age, was diagnosed with off label use and was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: tenosynovitis stenosans. Norditropin dosage: 4.40 Iu, Qd.

6615216-3 | Meningioma
on Feb 23, 2010 Female patient from FRANCE , weighting 141.1 lb, was diagnosed with growth hormone deficiency, epilepsy (What is epilepsy?), blood thyroid stimulating hormone abnormal, blood corticotrophin abnormal, gonadotrophin deficiency and was treated with Norditropin (View Usage). Patient had the following side effects: meningioma. Norditropin dosage: 0.6 Mg, Qd. During the same period patient was treated with ARTANE (3 Mg, Qd) (View Artane Review and Artane Label ), DEPAKENE (600 Mg, Qd) (View Depakene Review and Depakene Label ), LAMICTAL (100 Mg, Qd) (View Lamictal Review and Lamictal Label ), MODOPAR (187.5 Mg, Qd) (View Modopar Review and Modopar Label ), LEVOTHYROX (100 Ug, Qd) (View Levothyrox Review and Levothyrox Label ), HYDROCORTISONE (15 Mg, Qd) (View Hydrocortisone Review and Hydrocortisone Label ), CLIMASTON /01248201/ (6 Mg, Qd) (View Climaston /01248201/ Review and Climaston /01248201/ Label ). Patient was hospitalized.

6607229-2 | Emphysema
Patient was taking Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: emphysema on Feb 23, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 421.5 lb, was diagnosed with blood growth hormone and. Norditropin dosage: 0.25 Mg Qd Sq. Patient was hospitalized.

6598837-6 | Astrocytoma Malignant
Adverse event was reported on Feb 15, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: 0.2 Mg, Unk) was diagnosed with growth hormone deficiency and. Location: UNITED KINGDOM , 22 years of age, Patient experienced the following unwanted or unexpected effects: astrocytoma malignant.

6550348-X | Meningioma
on Jan 14, 2010 Female patient from FRANCE , 35 years of age, weighting 141.1 lb, was diagnosed with growth hormone deficiency, epilepsy (What is epilepsy?), blood thyroid stimulating hormone abnormal, blood corticotrophin abnormal, gonadotrophin deficiency, vitamin d deficiency and was treated with Norditropin (View Usage). Patient had the following side effects: meningioma. Norditropin dosage: 0.6 Mg, Qd. During the same period patient was treated with ARTANE (3 Mg, Qd) (View Artane Review and Artane Label ), DEPAKENE (600 Mg, Qd) (View Depakene Review and Depakene Label ), LAMICTAL (100 Mg, Qd) (View Lamictal Review and Lamictal Label ), MODOPAR (187.5 Mg, Qd) (View Modopar Review and Modopar Label ), LEVOTHYROXINE SODIUM (100 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (15 Mg, Qd) (View Hydrocortisone Review and Hydrocortisone Label ), CLIMASTON /01248201/ (6 Mg, Qd) (View Climaston /01248201/ Review and Climaston /01248201/ Label ), UVEDOSE (One Vial Per 3 Months) (View Uvedose Review and Uvedose Label ). Patient was hospitalized.

6546420-0 | Papilloedema
on Jan 14, 2010 Female patient from UNITED STATES , weighting 71.39 lb, was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: papilloedema. Norditropin dosage: . During the same period patient was treated with ESTRADIOL (0.00625 Mg Weekly) (View Estradiol Review and Estradiol Label ).

6540752-8 | Pancreatitis
Patient was taking Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis on Jan 13, 2010 from ITALY Additional patient health information: Female patient , 13 years of age, weighting 151.7 lb, was diagnosed with hypopituitarism and. Norditropin dosage: 0,033 Mg/kg/day 6 Weekly Doses. Patient was hospitalized.

6538884-3 | Back Pain, Epstein-barr Virus Associated Lymphoproliferative Disorder, Haemoglobin Decreased, Liver Disorder, Renal Impairment, Sepsis, Upper Respiratory Tract Infection
Adverse event was reported on Jan 11, 2010 by a Male patient taking Norditropin (View Usage) (Dosage: 1.5 Mg, Qd) was diagnosed with body height below normal and. Location: AUSTRALIA , 13 years of age, weighting 82.67 lb, Patient had the following side effects: back pain (What is back pain?), epstein-barr virus associated lymphoproliferative disorder, haemoglobin decreased, liver disorder, renal impairment, sepsis (What is sepsis?), upper respiratory tract infection. During the same period patient was treated with AZATHIOPRINE (50 Mg, Qd) (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (15 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), TACROLIMUS (12 Mg, Qd) (View Tacrolimus Review and Tacrolimus Label ), ROACCUTANE (10 Mg, Qd) (View Roaccutane Review and Roaccutane Label ), ENAPRIL /00574901/ (View Enapril /00574901/ Review and Enapril /00574901/ Label ), VALGANCICLOVIR HCL (450 Mg, Bid) (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ). Patient was hospitalized.

6538881-8 | Hypoglycaemic Seizure, Viral Infection
on Jan 05, 2010 Male patient from NEW ZEALAND , child 3 years of age, weighting 28.22 lb, was diagnosed with growth hormone deficiency and was treated with Norditropin (View Usage). After Norditropin was administered, patient had the following side effects: hypoglycaemic seizure, viral infection (What is viral infection?). Norditropin dosage: 0.5 Ml, Qd (when Being Compliant). During the same period patient was treated with HYDROCORTISONE (5 Mg, 5 Times A Day) (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6520281-8 | Autonomic Neuropathy
on Dec 22, 2009 Male patient from ITALY , 15 years of age, was treated with Norditropin (View Usage). Patient experienced the following unwanted or unexpected effects: autonomic neuropathy. Norditropin dosage: .

6518264-7 | Migraine
Patient was taking Norditropin (View Usage). Patient had the following side effects: migraine (What is migraine?) on Dec 22, 2009 from UNITED STATES Additional patient health information: Male patient , 54 years of age, . Norditropin dosage: 0.35 Mg Qd Sc. Patient was hospitalized.